Salvage Therapy of Refractory Hemophagocytic Lymphohistiocytosis with Alemtuzumab

BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome that remains difficult to treat. Even with current standard HLH therapy, only approximately half of patients will experience complete resolution of disease, and early mortality remains a significant...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Marsh, Rebecca A., Allen, Carl E., McClain, Kenneth L., Weinstein, Joanna L., Washko, Julie Kanter, Skiles, Jodi, Lee, Nadine D., Khan, Shakila P., Lawrence, Julia, Mo, Jun Q., Bleesing, Jack J., Filipovich, Alexandra H., Jordan, Michael B.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3410971/
https://ncbi.nlm.nih.gov/pubmed/22522603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24188
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky